335 related articles for article (PubMed ID: 19210946)
21. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
Vitiello B; Riddle MA; Yenokyan G; Axelson DA; Wagner KD; Joshi P; Walkup JT; Luby J; Birmaher B; Ryan ND; Emslie G; Robb A; Tillman R
J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
[TBL] [Abstract][Full Text] [Related]
22. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
[TBL] [Abstract][Full Text] [Related]
23. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
24. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
Wolfsperger M; Greil W; Rössler W; Grohmann R
J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of depressive and bipolar disorder patients with mixed features.
Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of bipolar disorders].
Schmauss M; Messer T
MMW Fortschr Med; 2009 Mar; 151(13):74-8. PubMed ID: 19504825
[No Abstract] [Full Text] [Related]
30. Pharmacotherapy of bipolar depression: an update.
Thase ME
Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacotherapy in bipolar disorders during childhood and adolescence].
Vloet JA; Hagenah UF
Z Kinder Jugendpsychiatr Psychother; 2009 Jan; 37(1):27-49, quiz 49-50. PubMed ID: 19105162
[TBL] [Abstract][Full Text] [Related]
32. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
34. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
35. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
[TBL] [Abstract][Full Text] [Related]
36. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
37. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
38. Bipolar disorders.
McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling.
Soares JC
Int Clin Psychopharmacol; 2000 Jul; 15(4):183-96. PubMed ID: 10954058
[TBL] [Abstract][Full Text] [Related]
40. Medical and substance use comorbidity in bipolar disorder.
Kemp DE; Gao K; Ganocy SJ; Caldes E; Feldman K; Chan PK; Conroy C; Bilali S; Findling RL; Calabrese JR
J Affect Disord; 2009 Jul; 116(1-2):64-9. PubMed ID: 19100627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
